4 Patents
- US122584092025Method of Assessing the Efficacy of a Test Agent for Modulating Programmed Death 1 (PD-1) Signaling by Using Anti-phosphotyrosinylated PD-1 Monoclonal Antibodies
President And Fellows Of Harvard College
0 cites - US121395352024Methods for Upregulating Immune Responses Using Combinations of Anti-rgmb and Anti-pd-1 Agents
Dana-farber Cancer Institute, Inc.
0 cites - US121039722024KIR3DL3 as an HHLA2 Receptor, Anti-hhla2 Antibodies, and Uses Thereof
Dana-farber Cancer Institute, Inc.
0 cites - US115847882023Compositions and Methods for Identification, Assessment, Prevention, and Treatment of Melanoma Using PD-L1 Isoforms
Dana-farber Cancer Institute, Inc.
0 cites